Vis enkel innførsel

dc.contributor.authorSchjøtt, Jan
dc.contributor.authorBöttiger, Ylva
dc.contributor.authorDamkier, Per
dc.contributor.authorReppe, Linda Amundstuen
dc.contributor.authorKampmann, Jens Peter
dc.contributor.authorChristensen, Hanne Rolighed
dc.contributor.authorSpigset, Olav
dc.date.accessioned2021-05-10T09:59:38Z
dc.date.available2021-05-10T09:59:38Z
dc.date.created2018-07-02T13:14:28Z
dc.date.issued2018
dc.identifier.citationMedicines. 2018, 5 (3), .en_US
dc.identifier.issn2305-6320
dc.identifier.urihttps://hdl.handle.net/11250/2754592
dc.description.abstractBackground: The aim of this study was to compare use of references in responses from Scandinavian drug information centres (DICs). Methods: Six different fictitious drug-related queries were sent to each of seven Scandinavian DICs. The six queries concerned adverse effects, pharmacokinetics, pregnancy, complementary medicine, polypharmacy, and breast feeding. References in the responses were categorised into five types of drug information sources: primary (original studies), secondary (reviews), tertiary (drug monographs, handbooks, etc.), DIC database, or personal communication. Results: Two hundred and forty-four references were used in the 42 responses. The mean number of references varied from 3.0 to 10.6 for the six queries. The largest difference between centres with regard to number of references used (range 1–17) was found for the query on complementary medicine. In total, 124 references (50.8%) were tertiary, and only 10 of the 42 responses (23.8%) did not have any tertiary references included. Complementary medicine, breast feeding, and pregnancy were query types associated with relatively frequent use of primary references. Use of DIC database was not uncommon, but personal communications were seldom used. Conclusions: Scandinavian DICs differ substantially in number and type of references to identical drug-related queries. Tertiary sources are mainly preferred irrespective of type of query.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleUse of references in responses from Scandinavian drug information centresen_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume5en_US
dc.source.journalMedicinesen_US
dc.source.issue3en_US
dc.identifier.doi10.3390/medicines5030066
dc.identifier.cristin1595185
dc.description.localcodeThis is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.source.articlenumber66en_US
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal